Interesting facts
Interesting Facts about N-[1-[2-(1H-indol-3-yl)ethyl]-4-piperidyl]benzamide
N-[1-[2-(1H-indol-3-yl)ethyl]-4-piperidyl]benzamide is a fascinating compound that captures the interest of scientists across various fields due to its intriguing structure and potential applications. Below are some compelling aspects of this compound:
- Pharmacological Relevance: This compound has been studied for its potential use in neurological therapeutics. Its indole structure is particularly notable, as indoles are found in many biologically active compounds, including neurotransmitters.
- Structural Complexity: The presence of both indole and piperidine rings contributes to its structural diversity, making it a fascinating subject for studies in medicinal chemistry.
- Research Potential: Numerous studies aim to evaluate the compound's efficacy as a drug candidate, particularly in targeting specific receptors in the brain, which could lead to advancements in treating disorders such as depression or anxiety.
- Hybrid Architecture: The unique combination of the piperidine and benzamide moieties offers intriguing possibilities for modifying its pharmacophore, enhancing its activity or selectivity towards certain biological targets.
- Natural Compounds Inspiration: Indole derivatives like this compound often mimic structures found in nature, showcasing how natural products inspire synthetic chemistry and drug design.
In summary, N-[1-[2-(1H-indol-3-yl)ethyl]-4-piperidyl]benzamide stands out as a compound with significant potential in medicinal chemistry, driven by its unique structural characteristics and alignment with pharmacologically active frameworks. Its continuous exploration could pave the way for future therapeutic agents.
Synonyms
INDORAMIN
26844-12-2
Indoramine
Indoramina
Indoraminum
Wy-21901
WY 21901
Baratol
N-[1-[2-(1H-indol-3-yl)ethyl]piperidin-4-yl]benzamide
Benzamide, N-(1-(2-(1H-indol-3-yl)ethyl)-4-piperidinyl)-
0Z802HMY7H
DTXSID7048370
Benzamide, N-[1-[2-(1H-indol-3-yl)ethyl]-4-piperidinyl]-
Wy21901
N-(1-(2-(1H-indol-3-yl)ethyl)piperidin-4-yl)benzamide
Doralese tiltab
RefChem:790998
DTXCID3028344
C02CA02
248-041-5
Indoramine;Wy 21901
CHEMBL279516
3-[2-(4-Benzamido-1-piperidyl)ethyl]indole
N-(1-(2-Indol-3-ylethyl)-4-piperidyl)benzamide
Doralese
N-[1-(2-Indol-3-ylethyl)-4-piperidyl]benzamide
Benzamide, N-(1-(2-indol-3-ylethyl)-4-piperidyl)-
Benzamide, N-[1-(2-indol-3-ylethyl)-4-piperidyl]-
Indoramine [INN-French]
Indoraminum [INN-Latin]
Indoramina [INN-Spanish]
NCGC00165810-01
EINECS 248-041-5
BRN 0494035
UNII-0Z802HMY7H
Indoramin [USAN:INN:BAN]
3-(2-(4-Benzamidopiperid-1-yl)ethyl)indole
N-(1-(2-(1H-Indol-3-yl)ethyl)-4-piperidinyl)benzamide
3-[2-(4-Benzamidopiperidino)ethyl]indole
INDORAMIN [INN]
INDORAMIN [MI]
Indoramin (USAN/INN)
INDORAMIN [USAN]
Maybridge3_004972
INDORAMIN [WHO-DD]
Oprea1_130443
SCHEMBL49517
GTPL501
MLS001182179
SCHEMBL29370437
CHEBI:135470
HMS1445B22
HMS2851P23
BDBM50033113
CCG-41146
NSC771684
PDSP1_001099
PDSP1_001423
PDSP2_001083
PDSP2_001407
AKOS015994528
AF-0013
DB08950
NSC-771684
IDI1_016359
HY-12760
SMR000567879
DB-315015
CS-0012358
NS00003913
D04531
SBI-0653871.0001
L001292
Q408963
SR-01000631243-1
BRD-K76953762-001-08-5
N-(1-[2-(1H-Indol-3-yl)ethyl]-4-piperidinyl)benzamide #
N-{1-[2-(1H-Indol-3-yl)-ethyl]-piperidin-4-yl}-benzamide
INDORAMINN-{1-[2-(1H-Indol-3-yl)-ethyl]-piperidin-4-yl}-benzamide
N-{1-[2-(1H-Indol-3-yl)-ethyl]-piperidin-4-yl}-benzamide (Indoramin)
N-{1-[2-(1H-Indol-3-yl)-ethyl]-piperidin-4-yl}-benzamide(Indoramin)
Solubility of N-[1-[2-(1H-indol-3-yl)ethyl]-4-piperidyl]benzamide
N-[1-[2-(1H-indol-3-yl)ethyl]-4-piperidyl]benzamide is a compound characterized by its unique structural features, which can significantly influence its solubility in various solvents.
Solubility Characteristics
The solubility of this compound can be categorized based on the following factors:
In summary, the solubility of N-[1-[2-(1H-indol-3-yl)ethyl]-4-piperidyl]benzamide is not straightforward and requires a thoughtful examination of environmental, structural, and chemical factors. As mentioned in studies regarding similar compounds, "the interplay between molecular structure and solubility is key to understanding pharmacokinetics." Thus, when working with this compound, one should always consider testing its solubility in various solvents under controlled conditions to gain insightful data for applications.